Thank you!

Your email has been successfully added to our mailing list.

×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
No thanks

BCAX – bicara therapeutics inc. (US:NASDAQ)

DELAYED
$
Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low
VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
BCAX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/11
04:47 pm
bcax
Form 4 Bicara Therapeutics Inc. For: Mar 09 Filed by: Mazumdar Claire
Low Report
Form 4 Bicara Therapeutics Inc. For: Mar 09 Filed by: Mazumdar Claire
Report
3/9
04:06 pm
bcax
Form 144 Bicara Therapeutics Inc. Filed by: Mazumdar Claire
Low Report
Form 144 Bicara Therapeutics Inc. Filed by: Mazumdar Claire
Report
3/6
07:27 pm
bcax
Form 4 Bicara Therapeutics Inc. For: Mar 04 Filed by: Mazumdar Claire
Medium Report
Form 4 Bicara Therapeutics Inc. For: Mar 04 Filed by: Mazumdar Claire
Report
3/6
04:02 pm
bcax
Form 144 Bicara Therapeutics Inc. Filed by: Mazumdar Claire
Medium Report
Form 144 Bicara Therapeutics Inc. Filed by: Mazumdar Claire
Report
3/5
07:10 pm
bcax
Form 4 Bicara Therapeutics Inc. For: Mar 03 Filed by: Cohlhepp Ryan
Low Report
Form 4 Bicara Therapeutics Inc. For: Mar 03 Filed by: Cohlhepp Ryan
Report
3/5
07:09 pm
bcax
Form 4 Bicara Therapeutics Inc. For: Mar 03 Filed by: Hyep Ivan
Low Report
Form 4 Bicara Therapeutics Inc. For: Mar 03 Filed by: Hyep Ivan
Report
3/5
07:06 pm
bcax
Form 4 Bicara Therapeutics Inc. For: Mar 03 Filed by: Raben David
Low Report
Form 4 Bicara Therapeutics Inc. For: Mar 03 Filed by: Raben David
Report
3/5
04:05 pm
bcax
Form 144 Bicara Therapeutics Inc. Filed by: Mazumdar Claire
Low Report
Form 144 Bicara Therapeutics Inc. Filed by: Mazumdar Claire
Report
3/4
04:33 pm
bcax
Form 144 Bicara Therapeutics Inc. Filed by: Hyep Ivan
Low Report
Form 144 Bicara Therapeutics Inc. Filed by: Hyep Ivan
Report
3/4
04:32 pm
bcax
Form 144 Bicara Therapeutics Inc. Filed by: Mazumdar Claire
Low Report
Form 144 Bicara Therapeutics Inc. Filed by: Mazumdar Claire
Report
3/4
04:21 pm
bcax
Form 144 Bicara Therapeutics Inc. Filed by: Raben David
Low Report
Form 144 Bicara Therapeutics Inc. Filed by: Raben David
Report
3/3
04:48 pm
bcax
Form 144 Bicara Therapeutics Inc. Filed by: Hyep Ivan
Medium Report
Form 144 Bicara Therapeutics Inc. Filed by: Hyep Ivan
Report
3/3
04:30 pm
bcax
Form 144 Bicara Therapeutics Inc. Filed by: Raben David
Medium Report
Form 144 Bicara Therapeutics Inc. Filed by: Raben David
Report
3/3
04:15 pm
bcax
Form 144 Bicara Therapeutics Inc. Filed by: Cohlhepp Ryan
Medium Report
Form 144 Bicara Therapeutics Inc. Filed by: Cohlhepp Ryan
Report
3/2
04:25 pm
bcax
Form SCHEDULE 13D/A Bicara Therapeutics Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Low Report
Form SCHEDULE 13D/A Bicara Therapeutics Inc. Filed by: RA CAPITAL MANAGEMENT, L.P.
Report
3/2
04:23 pm
bcax
Form 4 Bicara Therapeutics Inc. For: Feb 26 Filed by: Shah Rajeev M.
Low Report
Form 4 Bicara Therapeutics Inc. For: Feb 26 Filed by: Shah Rajeev M.
Report
2/27
04:17 pm
bcax
Form 4 Bicara Therapeutics Inc. For: Feb 25 Filed by: Cohlhepp Ryan
Medium Report
Form 4 Bicara Therapeutics Inc. For: Feb 25 Filed by: Cohlhepp Ryan
Report
2/26
04:09 pm
bcax
Form 8-K Bicara Therapeutics Inc. For: Feb 24
Low Report
Form 8-K Bicara Therapeutics Inc. For: Feb 24
Report
2/26
06:07 am
bcax
Form 424B5 Bicara Therapeutics Inc.
Medium Report
Form 424B5 Bicara Therapeutics Inc.
Report
2/25
04:03 pm
bcax
Form 144 Bicara Therapeutics Inc. Filed by: Cohlhepp Ryan
Medium Report
Form 144 Bicara Therapeutics Inc. Filed by: Cohlhepp Ryan
Report
2/25
06:02 am
bcax
Form FWP Bicara Therapeutics Inc. Filed by: Bicara Therapeutics Inc.
Medium Report
Form FWP Bicara Therapeutics Inc. Filed by: Bicara Therapeutics Inc.
Report
2/24
04:27 pm
bcax
Form 424B5 Bicara Therapeutics Inc.
Medium Report
Form 424B5 Bicara Therapeutics Inc.
Report
2/19
04:33 pm
bcax
Form 8-K Bicara Therapeutics Inc. For: Feb 19
Low Report
Form 8-K Bicara Therapeutics Inc. For: Feb 19
Report
2/17
04:12 pm
bcax
Form SCHEDULE 13G/A Bicara Therapeutics Inc. Filed by: Vestal Point Capital, LP
Low Report
Form SCHEDULE 13G/A Bicara Therapeutics Inc. Filed by: Vestal Point Capital, LP
Report
2/17
10:29 am
bcax
Form SCHEDULE 13G Bicara Therapeutics Inc. Filed by: T. Rowe Price Investment Management, Inc.
Low Report
Form SCHEDULE 13G Bicara Therapeutics Inc. Filed by: T. Rowe Price Investment Management, Inc.
Report
Latest Posts

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day
Information

Information

Support

Support

Contact us

Contact us

11201 N Tatum Blvd
Suite 300-79795
Phoenix, AZ 85028
info@newsquantified.com

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

11201 N Tatum Blvd
Suite 300-79795
Phoenix, AZ 85028
info@newsquantified.com
Stay in the know news, product updates and promotions.
Copyright Ⓒ News Quanitifed LLC 2012-2026, All product trademarks, names, logos, and brands are property of their respective owners. Image(s) or Footage (as applicable), used under license from Shutterstock.com. 3.0.0